Pernix Therapeutics (PTX)
Add to Watchlists Create an Alert
3.69
+0.09 +2.50%
NASDAQ
May 24, 5:01PM
BATS Real time
Currency in USD
Pro Data Export
Pernix Therapeutics Key Statistics
Currency in USD
Current Valuation
Dividends and Shares
| Shares Outstanding | 37.50M |
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Latest Dividend Date | |
| Latest Ex-Dividend Date | |
| Last Split Factor | 0.50 |
| Last Split Date | March 10, 2010 |
Profitability
| Gross Profit Margin Quarterly | 58.70% |
| Profit Margin Quarterly | -7.69% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 1.774 |
| Debt to Equity Ratio | 0.5556 |
| Free Cash Flow | 4.754M |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | 8.85% |
| Year to Date Stock Returns | -52.39% |
| 1 Year Stock Returns | -48.32% |
| 3 Year Stock Returns | -7.75% |
| 52 Week High | 9.20 |
| 52 Week Low | 2.93 |
Income Statement
Cash Flow Statement
| Cash from Financing TTM | 55.29M |
| Cash from Investing TTM | -64.90M |
| Cash from Operations TTM | -1.926M |
| Capital Expenditures Quarterly Pro | Go Pro |
Balance Sheet
| Cash and ST Investments | 23.02M |
| Long Term Debt | 43.64M |
| Total Assets | 251.45M |
| Liabilities | 172.91M |
| Shareholders Equity | 78.54M |
| Book Value | 78.54M |
| Book Value Per Share | 2.082 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
PTX News
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PTX | 3.69 | +0.09 | +2.50% | 139.20M |
New watchlist
